Related Experiment Video
Updated: Jun 24, 2026

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations
Published on: October 20, 2017
Economic burden of intracranial vascular malformations in adults: prospective population-based study
Clare E Miller1, Zahidul Quayyum, Paul McNamee
1Division of Clinical Neurosciences, University of Edinburgh, Edinburgh, UK.
Insights
Intracranial vascular malformations (IVMs) incur significant healthcare and lost productivity costs, particularly for brain arteriovenous malformations (AVMs) and those with intracerebral hemorrhage (ICH). Costs are highest for younger adults and those receiving interventional treatment.
Area of Science:
- Neurology
- Health Economics
- Public Health
Background:
- Intracranial vascular malformations (IVMs) are a primary cause of intracerebral hemorrhage (ICH) in young adults.
- No prior cost-of-illness studies have been conducted on unselected cohorts of IVMs.
Purpose of the Study:
- To determine the direct healthcare costs and indirect costs of lost productivity associated with brain arteriovenous malformations (AVMs) and cavernous malformations (CMs).
- To analyze cost variations based on patient demographics, clinical presentation, and treatment interventions.
Main Methods:
- A prospective, population-based study measured direct healthcare costs for 369 adults over 3 years post-diagnosis.
- Indirect costs of lost productivity were estimated by projecting questionnaire responses from a subset of patients.
- Costs included inpatient, outpatient, interventional, and brain imaging expenses.
Main Results:
- Total 3-year healthcare costs reached £5.96 million, with AVMs accounting for 90% and inpatient care for 75%.
- Median 3-year costs were significantly higher for patients with ICH, under 65 years, receiving interventions, and those with AVMs (£15,784) vs. CMs (£1385).
- Projected 3-year lost productivity costs amounted to £8.7 million, with higher estimates for AVMs (£17,111) vs. CMs (£6752) per respondent.
Conclusions:
- Intracranial vascular malformations represent a substantial economic burden due to healthcare and lost productivity costs.
- Costs are disproportionately higher in younger patients (<65 years), those experiencing ICH, undergoing interventions, and with AVMs compared to CMs.
- Further research on the cost-effectiveness of interventional treatments for IVMs is warranted.
Background And Purpose:
Although intracranial vascular malformations (IVMs) are the leading cause of intracerebral hemorrhage (ICH) in young adults, there has not been a cost-of-illness study on an unselected cohort.
Methods:
We measured the direct healthcare costs (inpatient, outpatient, intervention, and brain imaging) incurred by every adult within 3 years after their first presentation with a brain arteriovenous malformation (AVM) or cavernous malformation (CM) in a prospective, population-based study. We estimated the indirect cost of lost productivity for the whole cohort over the same period by projecting questionnaire responses from living consenting adults.
Results:
369 adults (AVM=229 [62%], CM=140 [38%]) incurred healthcare costs of pound 5.96 million over 3 years, of which AVMs accounted for 90%, inpatient care accounted for 75%, and the first year of care accounted for 69%. Median 3-year healthcare costs were statistically significantly higher for adults presenting with ICH, aged <65 years, receiving interventional treatment, and adults with AVMs rather than CMs ( pound 15,784 versus pound 1385, P<0.0005). Healthcare costs diminished with increasing AVM nidus size (P=0.005). Mean 3-year costs of lost productivity per questionnaire respondent (n=145) were pound 17,111 for AVMs and pound 6752 for CMs (P=0.1), and the projected 3-year cost of lost productivity for all 369 adults was pound 8.7 million.
Conclusions:
The costs of healthcare and lost productivity attributable to IVMs are considerable, and highest in those aged <65 years, presenting with ICH, receiving interventional treatment, and harboring AVMs rather than CMs. Long-term studies of the cost-effectiveness of interventional treatment are needed.
Related Concept Videos
Increased Intracranial Pressure l: Introduction
Increased Intracranial Pressure ll: Pathophysiology
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Cerebral Edema ll: Pathophysiology
